Rob H.A. Verhoeven
About
Rob H.A. Verhoeven is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, Rob H.A. Verhoeven has authored 213 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Surgery, 128 papers in Pulmonary and Respiratory Medicine and 66 papers in Oncology. Recurrent topics in Rob H.A. Verhoeven's work include Gastric Cancer Management and Outcomes (113 papers), Esophageal Cancer Research and Treatment (81 papers) and Esophageal and GI Pathology (37 papers). Rob H.A. Verhoeven is often cited by papers focused on Gastric Cancer Management and Outcomes (113 papers), Esophageal Cancer Research and Treatment (81 papers) and Esophageal and GI Pathology (37 papers). Rob H.A. Verhoeven collaborates with scholars based in Netherlands, United States and United Kingdom. Rob H.A. Verhoeven's co-authors include V.E.P.P. Lemmens, Johannes H.W. de Wilt, Irıs D. Nagtegaal, J.W.W. Coebergh, Grard A. P. Nieuwenhuijzen, Niek Hugen, Hanneke W.M. van Laarhoven, Ignace H. J. T. de Hingh, Margreet van Putten and Nelleke P.M. Brouwer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
In The Last Decade
Rob H.A. Verhoeven
199 papers receiving 4.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rob H.A. Verhoeven Netherlands | 35 | 2.5k | 1.7k | 1.5k | 539 | 503 | 213 | 4.6k | ||
| Mark S. Talamonti United States | 35 | 2.3k 0.9× | 1.6k 1.0× | 3.8k 2.6× | 542 1.0× | 939 1.9× | 96 | 6.0k | ||
| Matthew Guo United States | 22 | 1.7k 0.7× | 2.2k 1.3× | 1.5k 1.0× | 275 0.5× | 225 0.4× | 45 | 4.6k | ||
| Yolanda Barbáchano United Kingdom | 25 | 1.4k 0.6× | 1.2k 0.7× | 2.0k 1.4× | 211 0.4× | 150 0.3× | 57 | 3.4k | ||
| Amy M. Fremgen United States | 28 | 2.0k 0.8× | 1.2k 0.7× | 1.7k 1.1× | 1.8k 3.3× | 477 0.9× | 41 | 4.9k | ||
| Jean Couture Canada | 19 | 2.5k 1.0× | 1.2k 0.7× | 3.6k 2.4× | 231 0.4× | 682 1.4× | 38 | 5.1k | ||
| Johannes H.W. de Wilt Netherlands | 51 | 4.2k 1.7× | 2.1k 1.3× | 5.9k 3.9× | 228 0.4× | 802 1.6× | 320 | 9.3k | ||
| Graciela M. Nogueras‐González United States | 32 | 1.1k 0.4× | 920 0.6× | 1.0k 0.7× | 146 0.3× | 271 0.5× | 135 | 3.2k | ||
| Rebecca A. Nelson United States | 36 | 1.1k 0.5× | 1.3k 0.8× | 1.2k 0.8× | 101 0.2× | 623 1.2× | 124 | 3.5k | ||
| Scott A. Hundahl United States | 24 | 3.3k 1.3× | 4.3k 2.6× | 1.7k 1.1× | 1.7k 3.2× | 318 0.6× | 42 | 7.4k | ||
| Clare Peckitt United Kingdom | 31 | 1.1k 0.4× | 1.8k 1.1× | 1.7k 1.1× | 71 0.1× | 713 1.4× | 102 | 3.9k |
Countries citing papers authored by Rob H.A. Verhoeven
Since
Specialization
Citations
This map shows the geographic impact of Rob H.A. Verhoeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob H.A. Verhoeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob H.A. Verhoeven more than expected).
Fields of papers citing papers by Rob H.A. Verhoeven
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rob H.A. Verhoeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob H.A. Verhoeven. The network helps show where Rob H.A. Verhoeven may publish in the future.
Co-authorship network of co-authors of Rob H.A. Verhoeven
This figure shows the co-authorship network connecting the top 25 collaborators of Rob H.A. Verhoeven. A scholar is included among the top collaborators of Rob H.A. Verhoeven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob H.A. Verhoeven. Rob H.A. Verhoeven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Laarhoven, Hanneke W.M. van, Rob H.A. Verhoeven, Mark I. van Berge Henegouwen, et al.. (2025). Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands. EClinicalMedicine. 80. 103067–103067.
2.
Wu, Zhouqiao, Rob H.A. Verhoeven, Lucas Goense, et al.. (2025). A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy. Annals of Surgery. 282(5). 837–844.
3.
Vissers, Pauline A. J., Grard A. P. Nieuwenhuijzen, Maurice J.C. van der Sangen, et al.. (2025). A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients.. PubMed. 38(4).
4.
Silversmit, Geert, Philippe Nafteux, Camiel Rosman, et al.. (2025). Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population‐based comparison. International Journal of Cancer. 158(7). 1868–1880.
5.
Noordman, Bo Jan, H. de Graaf, Irene E.G. van Hellemond, et al.. (2025). The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based study. EClinicalMedicine. 81. 103109–103109.
6.
Pouw, Roos E., Yvette M. van der Linden, Rob H.A. Verhoeven, et al.. (2025). Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real‐world evidence study. International Journal of Cancer. 156(10). 1950–1960.
7.
Verhoeven, Rob H.A., Marije Slingerland, Bas P. L. Wijnhoven, et al.. (2024). 438P Adjuvant nivolumab after neoadjuvant chemoradiotherapy and surgery for patients with esophageal or gastroesophageal junction cancer: A nationwide real-world matched comparison of overall survival. Annals of Oncology. 35. S176–S177.
8.
Vissers, Pauline A. J., Laurens V. Beerepoot, Jelle P. Ruurda, et al.. (2024). Histopathological response to chemotherapy and survival of mucinous type gastric cancer. JNCI Journal of the National Cancer Institute. 117(2). 253–261.
9.
Erning, Felice N. van, et al.. (2023). Gender differences in tumor characteristics, treatment and survival of colorectal cancer: A population-based study. Cancer Epidemiology. 86. 102441–102441.
10.
Vissers, Pauline A. J., et al.. (2023). Conditional relative survival in nonmetastatic esophagogastric cancer between 2006 and 2020: A population‐based study. International Journal of Cancer. 152(12). 2503–2511.
11.
Verhoeven, Rob H.A., et al.. (2022). Impact of Age on Multimodality Treatment and Survival in Locally Advanced Rectal Cancer Patients. Cancers. 14(11). 2741–2741.
12.
Mohammad, Nadia Haj, et al.. (2022). SOURCE beyond first‐line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first‐line palliative systemic therapy. International Journal of Cancer. 152(6). 1202–1209.
13.
Brom, Linda, Pauline A. J. Vissers, Fabienne Warmerdam, et al.. (2022). Treatment decision‐making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study. Cancer Medicine. 11(12). 2427–2444.
14.
Kroese, Tiuri E., Yuko Takahashi, Florian Lordick, et al.. (2022). Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study. European Journal of Cancer. 179. 65–75.
15.
Jeene, Paul M., Héctor G. van den Boorn, Sherif Y. El Sharouni, et al.. (2022). Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia. Acta Oncologica. 61(7). 849–855.
16.
Vos, Elvira L., Masaya Nakauchi, Mithat Gönen, et al.. (2021). Risk of Lymph Node Metastasis in T1b Gastric Cancer. Annals of Surgery. 277(2). e339–e345.
17.
Vissers, Pauline A. J., Hester F. Lingsma, Nikki van Leeuwen, et al.. (2021). Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer. Cancer Epidemiology. 71(Pt A). 101897–101897.
18.
Dijksterhuis, Willemieke P.M., Rob H.A. Verhoeven, Sybren L. Meijer, et al.. (2020). Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study. Gastric Cancer. 23(4). 579–590.
19.
Geleijnse, Gijs, Rob H.A. Verhoeven, Felice N. van Erning, et al.. (2018). Using Process Mining to Evaluate Colon Cancer Guideline Adherence with Cancer Registry Data: a Case Study.. AMIA.
20.
Derikx, Lauranne, Loes H.C. Nissen, Joost P.H. Drenth, et al.. (2015). Better survival of renal cell carcinoma in patients with inflammatory bowel disease. Oncotarget. 6(35). 38336–38347.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mark S. Talamonti Breakdown of academic impact, for papers by Matthew Guo Breakdown of academic impact, for papers by Yolanda Barbáchano Breakdown of academic impact, for papers by Amy M. Fremgen Breakdown of academic impact, for papers by Jean Couture Breakdown of academic impact, for papers by Johannes H.W. de Wilt Breakdown of academic impact, for papers by Graciela M. Nogueras‐González Breakdown of academic impact, for papers by Rebecca A. Nelson Breakdown of academic impact, for papers by Scott A. Hundahl Breakdown of academic impact, for papers by Clare Peckitt